TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Aurion Biotech has introduced AURN001, a novel treatment developed for addressing corneal oedema resulting from corneal endothelial disease....
Dizal has introduced golidocitinib as a pioneering treatment specifically for adult patients suffering from relapsed or refractory peripheral T-cell lymphoma, a form of aggressive non-Hodgkin lymphoma...
Cranbury Pharmaceuticals has introduced a groundbreaking product, Emflaza® oral suspension, designed specifically for treating Duchenne muscular dystrophy...
Loma Linda University Health has achieved a groundbreaking milestone with the development of a pioneering gene therapy for hemophilia B, complemented by dirloctocogene samoparvovec, an advanced...
Spinogenix has discovered a novel treatment, SPG302, for Amyotrophic Lateral Sclerosis. SPG302 is a once-daily pill developed as a regenerative therapy for ALS...
UC San Diego Health has unveiled a pioneering immunotherapy treatment for metastatic melanoma, heralding a breakthrough in cancer care. This novel approach utilises personalised cellular therapy...
Vera Therapeutics has introduced Atacicept, a breakthrough therapy for Immunoglobulin A Nephropathy (IgAN). Atacicept is an investigational recombinant fusion protein that incorporates the soluble...
Biogen has developed QALSODY®, a groundbreaking therapy for adults with amyotrophic lateral sclerosis linked to a mutation in the superoxide dismutase 1 gene...
Merus has introduced a pioneering treatment called petosemtamab, tailored for patients grappling with recurrent or metastatic head and neck squamous cell carcinoma that has advanced despite prior treatment...
Roche has introduced inavolisib, an oral investigational therapy, combined with palbociclib and fulvestrant, for treating adult patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative...
